Neurology
Neurology
06/19/2017
The FDA has expanded the approval of a drug to include the treatment of adults with lower limb spasticity.
06/19/2017
Allergies
Allergies
06/16/2017
A new epipen will be available soon for patients with severe emergency allergic reactions. For more information on the drug, read more.
06/16/2017
Allergies
Allergies
06/16/2017
A new epipen will be available soon for patients with severe emergency allergic reactions. For more information on the drug, read more.
06/16/2017
Allergies
Allergies
06/16/2017
A new epipen will be available soon for patients with severe emergency allergic reactions. For more information on the drug, read more.
06/16/2017
opioid
opioid
06/09/2017
After careful consideration, the FDA has requested that a particular opioid analgesic be removed from the market.
06/09/2017
opioid
opioid
06/09/2017
After careful consideration, the FDA has requested that a particular opioid analgesic be removed from the market.
06/09/2017
opioid
opioid
06/09/2017
After careful consideration, the FDA has requested that a particular opioid analgesic be removed from the market.
06/09/2017
Treatment
Treatment
06/08/2017
The US Food and Drug Administration has approved 3 formulations of a commonly prescribed antibiotic in injection form.
06/08/2017
Schizophrenia
Schizophrenia
06/06/2017
Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.
06/06/2017
Schizophrenia
Schizophrenia
06/06/2017
Aristada recently received approval from the US Food and Drug Administration for a new and shorter dosing regimen, providing more options to patients and health care providers.
06/06/2017